Antares 2Q loss widens on R&D expenses | Medical Informer

Home

Home » Symptoms & Conditions » Arthritis » Antares 2Q loss widens on R&D expenses

Antares 2Q loss widens on R&D expenses

Posted on 09 August 2012. Tags: Antares, expenses, Loss, R&ampD, widens

Antares 2Q loss widens on R&D expenses
EWING, N.J. (AP) — Shares of Antares Pharma Inc. fell Wednesday after the company said its loss widened as it ramped up research spending on its injectable rheumatoid arthritis drug Vibex. The company reported a second-quarter loss of $ 2.8 million, or …

Full News here – Read more on Businessweek

Leave a Reply Cancel reply

Latest
Popular
Comments
Tags
Subscribe

Dermal fillers – a cosmetic surgery crisis in waiting? May 26, 2013
60 Seconds or Sow: How to Use Aspirin to Strengthen Tomato Defenses (SAR) – The Rusted Garden 2013 – Medical Informer Video May 26, 2013
Health insurance options for the recent graduate May 26, 2013
Use Avocado To Cure Erectile Dysfunction May 25, 2013
Bausch & Lomb Unit to Pay $33.5 Million on Conspiracy, Kickback Charges May 25, 2013

lasik November 2, 2011
CT scan (3/13) – Medical Informer Video November 12, 2011
Cosmetic Surgery Documentary – Ethnic Nose Job – Plastic Surgeon Beverly Hills – Medical Informer Video November 23, 2011
Aspirin Toner – Medical Informer Video November 29, 2011
Animation about diabetes and the body. – Medical Informer Video December 5, 2011